Conatus Pharmaceuticals Inc. (CNAT)

[nsomniyak]

I still like CNAT long term. We'll get a read on whether the market likes it, and institutions like it, after the offering closes early next week. We may see some institutional filings, and hopefully we will see that the offering was fully oversubscribed (indicating demand) and the price snap back. Long term I still think they are likely to be bought by Novartis.